Terms: = Pancreatic cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
11 results:
1. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
2. Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Phototherapy of pancreatic cancer.
Liu L; Xiao X; Guo J; Wang J; Liu S; Wang M; Peng Q; Jiang N
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16539-16551. PubMed ID: 36961248
[TBL] [Abstract] [Full Text] [Related]
3. Upregulation of SOCS2 causes mitochondrial dysfunction and promotes ferroptosis in pancreatic cancer cells.
He M; Cai Y; Yuan Z; Zhang L; Lu H
Acta Biochim Pol; 2023 Feb; 70(1):163-168. PubMed ID: 36735705
[TBL] [Abstract] [Full Text] [Related]
4. Chlorogenic acid depresses cellular bioenergetics to suppress pancreatic carcinoma through modulating c-Myc-tfr1 axis.
Yang H; Said AM; Huang H; Papa APD; Jin G; Wu S; Ma N; Lan L; Shangguan F; Zhang Q
Phytother Res; 2021 Apr; 35(4):2200-2210. PubMed ID: 33258205
[TBL] [Abstract] [Full Text] [Related]
5. Elucidation and Structural Modeling of cd71 as a Molecular Target for Cell-Specific Aptamer Binding.
Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
[TBL] [Abstract] [Full Text] [Related]
6. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs pancreatic Tumor Growth.
Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
[TBL] [Abstract] [Full Text] [Related]
7. Identification of stable housekeeping genes in response to ionizing radiation in cancer research.
Iyer G; Wang AR; Brennan SR; Bourgeois S; Armstrong E; Shah P; Harari PM
Sci Rep; 2017 Mar; 7():43763. PubMed ID: 28262749
[TBL] [Abstract] [Full Text] [Related]
8. Using Quantitative Seroproteomics to Identify Antibody Biomarkers in pancreatic cancer.
Jhaveri DT; Kim MS; Thompson ED; Huang L; Sharma R; Klein AP; Zheng L; Le DT; Laheru DA; Pandey A; Jaffee EM; Anders RA
Cancer Immunol Res; 2016 Mar; 4(3):225-33. PubMed ID: 26842750
[TBL] [Abstract] [Full Text] [Related]
9. Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line.
Hollevoet K; Mason-Osann E; Müller F; Pastan I
PLoS One; 2015; 10(3):e0122462. PubMed ID: 25803818
[TBL] [Abstract] [Full Text] [Related]
10. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia.
Barth BM; I Altinoğlu E; Shanmugavelandy SS; Kaiser JM; Crespo-Gonzalez D; DiVittore NA; McGovern C; Goff TM; Keasey NR; Adair JH; Loughran TP; Claxton DF; Kester M
ACS Nano; 2011 Jul; 5(7):5325-37. PubMed ID: 21675727
[TBL] [Abstract] [Full Text] [Related]
11. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.
Barth BM; Sharma R; Altinoğlu EI; Morgan TT; Shanmugavelandy SS; Kaiser JM; McGovern C; Matters GL; Smith JP; Kester M; Adair JH
ACS Nano; 2010 Mar; 4(3):1279-87. PubMed ID: 20180585
[TBL] [Abstract] [Full Text] [Related]
